Purchase Order 75D30121P10611
- Not listed
- This federal contract award was issued by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The $125,565.50 firm fixed price purchase order is for the delivery of SARS COV2 RNA control products to support COVID-19 research and diagnostics efforts. The contract does not have a set-aside designation. Twist Bioscience provides various...
- This is a federal contract award to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California, for the provision of SARS-CoV-2 RNA controls. The contract, valued at $82,080.66, was awarded by the Centers for Disease Control and Prevention (CDC) on July 29, 2020 and has an ultimate completion date of August 29, 2020. The contract is a firm fixed price purchase order and does not have a set-aside designation. Twist Bioscience has been a key provider of...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Twist Bioscience Corporation, a for-profit synthetic biology company, to provide TWIST RNA products for the FLUSC2 MULTIPLE program. The $51,160.00 contract does not have a set-aside designation and is scheduled for completion by April 30, 2024. Twist Bioscience, a manufacturer of goods, has previously received numerous federal contracts to supply synthetic...
- The Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) awarded a firm fixed price purchase order contract to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $220,065.50 contract is for the provision of SARS COV 2 RNA controls to support COVID-19 research efforts. Twist Bioscience, as a prime contractor, has provided various research products to federal agencies including the NIH, VA, and...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $157,390 firm fixed price purchase order contract to Twist Bioscience Corporation for the delivery of "LAP SUPPLIES." This contract, which has a completion date of September 14, 2025, does not include a set-aside designation. Twist Bioscience is a synthetic biology company that specializes in the manufacture of high-quality synthetic DNA products and services. Through this contract, Twist Bioscience will likely provide...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $97,588 contract is for the provision of COVID-19 DNA constructs, which likely support genomics research, disease surveillance, and public health initiatives. This contract does not have a set-aside designation. Twist...
- This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The contract is for the provision of biological and reagent materials, with a ceiling value of $12,206.25 and a period of performance through September 4, 2025. There is no set-aside designation for this...
- This federal contract award to Twist Bioscience Corporation, a synthetic biology company in South San Francisco, CA, is for the delivery of COVID-19 DNA constructs. The $29,671.85 firm fixed price purchase order was awarded on June 4, 2020 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract does not have a set-aside designation. Through this award, as well as previous contracts and grants, Twist...
- This is a firm fixed-price purchase order awarded by the Southeast Area of a civilian federal agency to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The contract, valued at $60,860.55, is for the provision of TWIST 96-PLEX LIBRARY PREP KIT 10X96 SAMPLES. This contract has no set-aside designation. Twist Bioscience has a history of delivering specialized scientific products and services to various federal agencies, including the...
- This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...
This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract, valued at $578,224.78, is for the delivery of SC2 POSITIVE CONTROL SYNTHETIC RNA CONTROL MATERIAL. This contract is not associated with a set-aside program. Twist Bioscience has been awarded numerous federal contracts, primarily as a prime contractor, to provide synthetic DNA products and next-generation sequencing services to support genomics research, disease surveillance, and public health initiatives for agencies such as the National Institutes of Health (NIH), Department of Veterans Affairs (VA), and Department of the Air Force. The company has also received federal grant funding, including a sub-award from the University of Massachusetts Medical School, to develop rapid COVID-19 diagnostic tests utilizing its synthetic biology capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | ($38k) | 6/25/24 | |
| P00001 | Other Administrative Action | $0 | 3/11/21 | |
| Not listed | Not listed | $578.2k | 3/11/21 |